AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

Enzalutamide

10 registrations across 3 African markets— 10 active

Markets with Enzalutamide

🇿🇦South Africa
8 registrations
8 active
🇰🇪Kenya
1 registration
1 active
🇹🇿Tanzania
1 registration
1 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
ENZACARE 40
Capsule, Hard
🇰🇪KenyaJavia International LimitedactiveJan 2030
NUXTAND🇿🇦South AfricaCipla Medpro (Pty) LtdactiveMar 2028
XZALU🇿🇦South AfricaCipla Medpro (Pty) LtdactiveMar 2028
ENZALUTAMIDE 40 mg CIPLA🇿🇦South AfricaCipla Medpro (Pty) LtdactiveFeb 2028
ENZUTIX🇿🇦South AfricaEurolab (Pty) LtdactiveJan 2028
DIZALUM🇿🇦South AfricaAurogen South Africa (Pty) LtdactiveJan 1900
ZILADE🇿🇦South AfricaAurogen South Africa (Pty) LtdactiveJan 1900
DIZALET🇿🇦South AfricaAurogen South Africa (Pty) LtdactiveJan 1900
XTANDI 40 mg🇿🇦South AfricaAstellas Pharma (Pty) LtdactiveJan 1900
ENZASTIK 40
Capsules
🇹🇿TanzaniaEugia Pharma Specialities Limitedactive—

Enzalutamide in Africa — Regulatory Overview

Enzalutamide is registered across 3 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Kenya, Tanzania. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.